Get the full SpectaCell company profile
Access contacts, investors, buying signals & more
Pioneering a new generation of cell therapy analytics, Belgian startup SpectaCell has secured $6.8M in seed funding. The company is developing a platform that combines breakthrough imaging technology, single-cell analysis, and artificial intelligence to unlock biological insights previously unattainable at scale.
This seed round saw investment from imec, VIB, and Ghent University, supporting SpectaCell's vision to become a global standard for functional characterization of cell therapies.
Breakthrough medicines need breakthrough tools Immunotherapies are redefining the future of medicine, opening new ways to treat cancer and diseases of the immune system. But predicting which treatments will work remains a major challenge.
SpectaCell is developing a new cell analysis platform that shows how individual cells respond to potential treatments. It enables researchers to compare drug candidates and helps them decide which treatment to pursue. The company - the first spin-off from a long-standing research collaboration between imec, VIB and Ghent University - has raised €6 million in Seed funding to further develop and co
neuroClues
In a world where Neurological disorders will affect 1 person in 3 and where the number of parkinson's patient will double in the next decade, reaching 13 million patients. Our mission is to empower clinicians with Biomarkers allowing them to identify Neurological Disorders (Parkinson's Disease, Alzheimer's Disease and Multiple Sclerosis) years before visible symptoms. Our ambition with NeuroClues is to become the brain's stethoscope. We are a team of seasoned MedTech entrepreneurs and doctors with as purpose to help our healthcare system cross the chasm of technology with pragmatic solutions. We work from anywhere but our base camps are in Louvain-la-Neuve, Belgium & Paris, France & NY, USA. We’re are looking to connect with individuals, companies, investors and Key Opinion Leaders that share our ambition and mission and that would be willing to partner with us in order to bring NeuroClues to the EU and US market.
$11.3M Unknown
1 day ago
Spott
Add interactivity to your content with Spott. Get more value out of your published content by making it actionable and measurable in a multichannel environment. Spott is an interactive marketing & advertising platform with an overall score on Capterra of 4,6 out of 5. Get started with your free account on www.spott.ai.
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Walden Robotics United States | Seed | $300.0M | today |
| 2 |  Phinity Labs | Seed | $5.2M | today |
| 3 |
$21.0M Series a
2 days ago
| $7.2B |
| 2y ago |
| 3 |  GRAIL United States | Unknown | $7.1B | 2y ago |
| 4 |  Illumina United States | Unknown | $7.1B | 2y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 8mo ago |
 CRSHMARKET |
| Seed |
| $3.5M |
| today |
| 4 |  TrndX.ai United States | Seed | $3.2M | today |
| 5 |  Peppermint Switzerland | Seed | $4.7M | today |
Trusted by 200+ sales teams
imec
INCUBATOR, ACCELERATOR
VIB
VC
Unlock 1 more investor and reach their contacts directly.
Start free trial
golbriak-space
Recently received
Phinity Labs
Recently received
emerald-ai
Recently received
